×

Tumor-targeted optical contrast agents

  • US 7,198,778 B2
  • Filed: 09/03/2003
  • Issued: 04/03/2007
  • Est. Priority Date: 01/18/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound of formula

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×